<html><body><h2>Case: 2289423</h2><h3> CDS Time: 1969-02-10</h3>
<patient name=2289423>
69.0 year old White_Non-Hispanic Male
<p><b>Lab & Note Entry Values:</b> <table>
<b><tr><td width="200">Lab</td><td width="200">Value</td><td width="200">Date</td></tr></b>
<tr><td width="200">Age</td><td width="200">69</td><td width="200">1970-1-1</td></tr>
<tr><td width="200">Calcium</td><td width="200">8</td><td width="200">1969-2-9</td></tr>
<tr><td width="200">Alkaline_phosphatase</td><td width="200">110</td><td width="200">1969-2-9</td></tr>
<tr><td width="200">Phosphorus</td><td width="200">6</td><td width="200">1969-2-9</td></tr>
<tr><td width="200">Chloride</td><td width="200">103.0</td><td width="200">1969-2-9</td></tr>
<tr><td width="200">Diastolic_BP</td><td width="200">71</td><td width="200">1969-2-9</td></tr>
<tr><td width="200">Weight</td><td width="200">148</td><td width="200">1969-2-9</td></tr>
<tr><td width="200">Uric_Acid</td><td width="200">4</td><td width="200">1969-2-9</td></tr>
<tr><td width="200">Triglycerides</td><td width="200">131</td><td width="200">1969-2-9</td></tr>
<tr><td width="200">SGOT</td><td width="200">23</td><td width="200">1969-2-9</td></tr>
<tr><td width="200">Total_Cholesterol</td><td width="200">166</td><td width="200">1969-2-9</td></tr>
<tr><td width="200">Systolic_BP</td><td width="200">164</td><td width="200">1969-2-9</td></tr>
<tr><td width="200">Total_Bilirubin</td><td width="200">0</td><td width="200">1969-2-9</td></tr>
<tr><td width="200">Height</td><td width="200">70</td><td width="200">1969-2-9</td></tr>
<tr><td width="200">Potassium</td><td width="200">6</td><td width="200">1969-2-9</td></tr>
<tr><td width="200">Cholesterol</td><td width="200">166</td><td width="200">1969-2-9</td></tr>
<tr><td width="200">BUN</td><td width="200">55</td><td width="200">1969-2-9</td></tr>
<tr><td width="200">HCT</td><td width="200">33</td><td width="200">1969-2-9</td></tr>
<tr><td width="200">HGB</td><td width="200">11</td><td width="200">1969-2-9</td></tr>
<tr><td width="200">Sodium</td><td width="200">141</td><td width="200">1969-2-9</td></tr>
<tr><td width="200">Albumen</td><td width="200">4</td><td width="200">1969-2-9</td></tr>
<tr><td width="200">Creatinine</td><td width="200">7.4</td><td width="200">1969-2-9</td></tr>
<tr><td width="200">Pulse</td><td width="200">93</td><td width="200">1969-2-9</td></tr>
<tr><td width="200">PLT</td><td width="200">247</td><td width="200">1969-2-9</td></tr>
<tr><td width="200">WBC</td><td width="200">9</td><td width="200">1969-2-9</td></tr>
<tr><td width="200">eGFR</td><td width="200">43</td><td width="200">1968-10-27</td></tr>
<tr><td width="200">SGPT</td><td width="200">34</td><td width="200">1969-2-9</td></tr>
<tr><td width="200">End-Stage_Renal_Disease</td><td width="200"></td><td width="200">1968-9-11</td></tr>
<tr><td width="200">Hypertension</td><td width="200"></td><td width="200">1969-2-9</td></tr>
<tr><td width="200">kidney</td><td width="200"></td><td width="200">1969-2-9</td></tr>
<tr><td width="200">Renovascular_Disease</td><td width="200"></td><td width="200">1968-10-21</td></tr>
<tr><td width="200">smoking</td><td width="200"></td><td width="200">1968-9-10</td></tr>
<tr><td width="200">Race</td><td width="200">White_Non-Hispanic</td><td width="200"></td></tr>
<tr><td width="200">Sex</td><td width="200">Male</td><td width="200"></td></tr>
<tr><td width="200">tobacco use</td><td width="200"></td><td width="200">1968-9-10</td></tr>
<tr><td width="200">Tobacco_Use</td><td width="200"></td><td width="200">1968-9-10</td></tr>
</table>
<p><b>Medications:</b> tacrolimus(10.0) aspirin(0.0) hydralazine(20.0) Insulin(0.04) 
<p><b>Problems:</b> <table>
<tr><td width="200"><b>Problem Class</b></td><td width="200"><b>First/Last Dates Reported</b></td><td width="200"></td></tr>
<tr><td width="200">Transplant recipients</td>
<td width="200">1969-02-09</td>
<td width="200"> kidney()</td></tr>
<tr><td width="200">Isolated_Systolic_Hypertension</td>
<td width="200"></td>
<td width="200"> Isolated Systolic Hypertension[Treatment_Systolic_BP(164/null) && Treatment_Diastolic_BP(71/null)]()</td></tr>
<tr><td width="200">Laboratory_Test_Result_Syndrome</td>
<td width="200"></td>
<td width="200"> Hyperkalemia[Potassium(5.9/1969-2-9)]()</td></tr>
<tr><td width="200">Renal_insufficiency_w_creat>=2.1</td>
<td width="200"></td>
<td width="200"> Renal Insufficiency[Creatinine(7.4/1969-2-9)]()</td></tr>
<tr><td width="200">Target_Organ_Damage_Clinical_Cardiovascular_Disease</td>
<td width="200"></td>
<td width="200"> TOD/CCD[Presence of CKD (lab or ICD9)]()</td></tr>
<tr><td width="200">Isolated_Systolic_Hypertension K >=3.5</td>
<td width="200"></td>
<td width="200"> Isolated Systolic Hypertension[presence of isolated systolic hypertension && Potassium(5.9/1969-2-9)]()</td></tr>
<tr><td width="200">K>5.5 and absence ACE</td>
<td width="200"></td>
<td width="200"> Hyperkalemia[Potassium(5.9/1969-2-9) && ACE I not being used]()</td></tr>
<tr><td width="200">Major Cardiovascular Risk Factor</td>
<td width="200"></td>
<td width="200"> Major Cardiovascular Risk Factor[Age(69.0/1970-1-1) && Sex(Male)]()</td></tr>
<tr><td width="200">CKD by eGFR</td>
<td width="200"></td>
<td width="200"> CKD by eGFR[eGFR(43.0/1968-10-27)]()</td></tr>
<tr><td width="200">CKD by eGFR or ICD9 codes</td>
<td width="200"></td>
<td width="200"> CKD[eGFR(43.0/1968-10-27)]()</td></tr>
<tr><td width="200">Age > 65</td>
<td width="200"></td>
<td width="200"> age > 65 years[Age(69.0/1970-1-1)]()</td></tr>
<tr><td width="200">on >= 1 med</td>
<td width="200"></td>
<td width="200"> Combination therapy for HTN[Antihypertensive_Agents]()</td></tr>
<tr><td width="200">On 1 drug and there exists contraindicated drug or a compelling drug not given</td>
<td width="200"></td>
<td width="200"> On 1 drug and there exists contraindicated drug or a compelling drug not given[there exists a compellingly indicated drug that is not already given]()</td></tr>
<tr><td width="200">Absence of Stage D HF</td>
<td width="200"></td>
<td width="200"> Absence of Stage D HF[Not Stage D HF (refractory end stage HF)Stage D HF (refractory end stage HF)]()</td></tr>
<tr><td width="200">High Risk for HF and DM, HTN, or atherosclerotic vascular disease</td>
<td width="200"></td>
<td width="200"> High Risk for HF and DM, HTN, or atherosclerotic vascular disease[Presence of hypertension && Absence of HF]()</td></tr>
<tr><td width="200">Male and most recent creatinine>2.5</td>
<td width="200"></td>
<td width="200"> Male and most recent creatinine>2.5[Sex(Male) && Creatinine(7.4/1969-2-9)]()</td></tr>
<tr><td width="200">Most recent K>=5</td>
<td width="200"></td>
<td width="200"> Most recent K>=5[Potassium(5.9/1969-2-9)]()</td></tr>
<tr><td width="200">Renal-Urinary_Diseases</td>
<td width="200">1968-10-21</td>
<td width="200"> Renovascular_Disease()</td></tr>
<tr><td width="200">Hypertension_Inclusive</td>
<td width="200">1969-02-09</td>
<td width="200"> Hypertension()</td></tr>
<tr><td width="200">Psychiatric_Diseases</td>
<td width="200">1968-09-10</td>
<td width="200"> Tobacco_Use()</td></tr>
<tr><td width="200"> <b>Others</b></td>
<td width="200">1968-09-11</td>
<td width="200"> End-Stage_Renal_Disease()
<tr> <td width="200"></td>
<td width="200">1968-09-10</td>
<td width="200"> tobacco use()
<tr> <td width="200"></td>
<td width="200">1968-09-10</td>
<td width="200"> smoking()
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Race()
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Sex()
</table><p>
</patient>
<h1 align="center">ATHENA Heart Failure Guideline</h1>
<b>Patient classification:</b> <ul>
<li>ATHENA Heart Failure Guideline: true[because <i> Eligibility criteria </i> evaluate to <b>true</b><i>(Not Stage D HF (refractory end stage HF)Stage D HF (refractory end stage HF))</i>]
</ul>
<b>Scenario choice:</b> Stage A HF
<b>Scenario choice:</b> Stage C HF
<p>
<b>Goal:</b> SBP < 140 and DBP < 90(absence of diabetes mellitus)
<p><b>Reached goal?</b> failed(Treatment_Systolic_BP(164/null))
<p>
<b>Goal:</b> LDL< 130 mg/dL(2+ Risk Factors)
<p><b>Reached goal?</b> unknown(LDL_Cholesterol(no value))
<p><b>Messages by Types</b>
<ul>
<li><b>Class I</b>
<ul>
<li>In patients at high risk for developing HF, systolic and diastolic hypertension should be controlled in accordance with contemporary
guidelines. (Level of Evidence: A)
<li>Patients at high risk for developing HF should be counseled to avoid behaviors that may increase the risk of HF (e.g., smoking, excessive alcohol consumption, and illicit drug use). (Level of
Evidence: C)
<li>Healthcare providers should perform periodic evaluation for signs
and symptoms of HF in patients at high risk for developing HF.
(Level of Evidence: C)
</ul>
<li><b>Class III</b>
<ul>
<li>Routine use of nutritional supplements solely to prevent the development of structural heart disease should not be recommended for patients at high risk for developing HF. (Level of
Evidence: C)
</ul>
</ul>
<p><b>Action Choices</b>
<ul>
<li><b>Stage A messages</b><br>
<ul>
<li><b>Hypertension control <font color=FF0000>preferred</font></b>(rule in criterion<i> BP not under control</i> evaluate to <b> true</b> because <i>BP not under controlTreatment_Systolic_BP(164/null)</i>)])
In patients at high risk for developing HF, systolic and diastolic hypertension should be controlled in accordance with contemporary
guidelines. (Level of Evidence: A)
<li><b>behavior control <font color=FF0000>preferred</font></b>(rule in criterion<i> true</i> evaluate to <b> true</i>)])
Patients at high risk for developing HF should be counseled to avoid behaviors that may increase the risk of HF (e.g., smoking, excessive alcohol consumption, and illicit drug use). (Level of
Evidence: C)
<li><b>Periodic evaluation <font color=FF0000>preferred</font></b>(rule in criterion<i> true</i> evaluate to <b> true</i>)])
Healthcare providers should perform periodic evaluation for signs
and symptoms of HF in patients at high risk for developing HF.
(Level of Evidence: C)
<li><b>not use nutritional supplements <font color=FF0000>preferred</font></b>(rule in criterion<i> true</i> evaluate to <b> true</i>)])
Routine use of nutritional supplements solely to prevent the development of structural heart disease should not be recommended for patients at high risk for developing HF. (Level of
Evidence: C)
</ul>
<li><b> </b><br>
<ul>
<li><b>stage A drug choices <font color=FF0000>preferred</font></b>(strict rule-in condition<i> DM or HTN or atherosclerotic vascular disease</i> evaluate to <b> true</b> because <i>Presence of hypertension</i>)])

</ul>
</ul>
<b>Considerations for adding drug: </b><ul><li>Ace_Inhibitor(Captopril, Lisinopril, Enalapril)<ul><li>Relative indications:  High Risk for HF and DM, HTN, or atherosclerotic vascular disease(High Risk for HF and DM, HTN, or atherosclerotic vascular disease[Presence of hypertension && Absence of HF]) <li>rec add ace: dose adjustent based on kidney functio(Refer to specific ACE Inhibitor dose adjustments based on kidney function.)<li>monitoring renal function and K(Need to find content)<li>preference: preferred</ul><li>ARB<ul><li>Relative indications:  High Risk for HF and DM, HTN, or atherosclerotic vascular disease(High Risk for HF and DM, HTN, or atherosclerotic vascular disease[Presence of hypertension && Absence of HF]) <li>preference: preferred</ul></ul></body></html>